Abc Viscoflu 3mg/ml Syrup Treatment of Respiratory Ailments 200ml bottle

Syrup based on Ambroxol hydrochloride.

Therapeutic indications

Viscomucil Syrup is used in the treatment of acute respiratory diseases characterized by thick and viscous hypersecretion.

Dosage and Posology

The drug should be taken according to the following doses and methods:

• Adults: 10 ml (30 mg) 3 times a day.
• Children 2 to 5 years: 2.5ml (7.5mg) 3 times a day.
• Children over 5 years: 5 ml (15 mg) 3 times a day.

It is recommended to take the syrup after meals. Do not use Viscomucil for prolonged treatments.

Overdose

Data on ambroxol overdose are limited. Symptoms corresponding to the undesirable effects described are to be expected. If necessary, implement suitable symptomatic and supportive therapy.

Contraindications

• Hypersensitivity to the active substance or to any of the excipients
• Severe hepatic and / or renal disorders
• The drug is contraindicated in children under 2 years of age

Side effects

• Rarely: tiredness, dry mouth, rhinorrhea, dysuria, headache, gastrointestinal disturbances (heartburn, dyspepsia, constipation, nausea and vomiting), contact dermatitis or other allergic reactions (especially skin rashes).
• Unknown frequency: bronchial obstruction.

Pregnancy and breastfeeding

For ambroxol no clinical data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal / fetal development, parturition or postnatal development. Caution should be exercised when prescribing the medicine to pregnant women. In pregnancy, drugs should only be prescribed if the expected benefit to the mother is considered to be greater than the risk to the fetus. All medications should be avoided, if possible, during the first trimester of pregnancy. The drug is excreted in breast milk. The use of ambroxol by the mother can cause undesirable effects in the infant; therefore, a decision must be made whether to discontinue breastfeeding or treatment with the drug, taking into account the importance of the drug to the mother.

Special warnings

Viscomucil should be administered with caution in patients with peptic ulcer. Due to the sorbitol present in the formulation, people with rare hereditary forms of fructose intolerance should not take this medicine. The amount of sorbitol contained in this medicinal product may cause a mild laxative effect.

The caloric value of sorbitol is 2.6 kcal / g. The product contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which can cause allergic reactions (including delayed type). Mucolytics can induce bronchial obstruction in children less than 2 years of age. In fact, the drainage capacity of the bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract. They should therefore not be used in children under 2 years of age.

Expiry and retention

Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored.

Warning : do not use the medicine after the expiry date indicated on the package.

Composition

100 ml of Viscomucil contain:

Active principle

Ambroxol hydrochloride 300 mg

Excipients

Sorbitol, glycerin, methyl para-hydroxybenzoate; propyl para-hydroxybenzoate; raspberry essence; purified water.